Showing results (251-260 of 264) with videos related to
Sort By:
Pageof 27
Palliative & Supportive Care|May 21, 2026
Frailty and the confidence to plan ahead: Decision-making self-efficacy and advance care planning among older adults receiving home healthcareChi Hsien Huang, Cheng-Pei Lin, Kelly Yen-Chih Chen, et al.European Journal of Pharmacology|September 15, 2011
Effect of thymol on Ca2+ homeostasis and viability in human glioblastoma cellsShu-Shong Hsu, Ko-Long Lin, Chiang-Ting Chou, et al.Journal of Receptor and Signal Transduction Research|June 23, 2015
The mechanism of protriptyline-induced Ca2+ movement and non-Ca2+-triggered cell death in PC3 human prostate cancer cellsHong-Tai Chang, Chiang-Ting Chou, Chia-Cheng Yu, et al.Nature Communications|April 1, 2025
Complete biosynthetic pathway of furochromones in Saposhnikovia divaricata and its evolutionary mechanism in Apiaceae plantsJian-Lin Zou, Hong-Ye Li, Bao Nie, et al.Cells|July 13, 2026
Distinct Innate and Adaptive Immune Modules Differentially Associate with HIV Reservoir Size and Decay During Early Antiretroviral TherapyWei-Zhe Li, Hui-Huang Huang, Hui-Fang Wang, et al.Emerging Microbes & Infections|March 26, 2025
GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIVHui-Fang Wang, Chao Zhang, Li-Ping Zhang, et al.The Chinese Journal of Physiology|February 18, 2015
Effect of methoxychlor on Ca²⁺ homeostasis and apoptosis in HA59T human hepatoma cellsChi-Ting Horng, Chiang-Ting Chou, Hui-Wen Tseng, et al.Military Medical Research|August 20, 2024
Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer in the past 20 years and future implicationsJia-Kun Li, Tong Tang, Hui Zong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2024
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG StudyJin-Ji Yang, Yan Zhang, Lin Wu, et al.The Lancet. Oncology|December 9, 2025
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 studyYi-Long Wu, Yu Yao, Jin-Ji Yang, et al.Pageof 27